LeMaitre Vascular Inc
NASDAQ:LMAT
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
52.06
107.97
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one LMAT stock under the Base Case scenario is 54.085 USD. Compared to the current market price of 105.425 USD, LeMaitre Vascular Inc is Overvalued by 49%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
LeMaitre Vascular Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for LMAT cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
LeMaitre Vascular Inc
Balance Sheet Decomposition
LeMaitre Vascular Inc
Current Assets | 227.1m |
Cash & Short-Term Investments | 123.9m |
Receivables | 32.3m |
Other Current Assets | 71m |
Non-Current Assets | 149.9m |
PP&E | 41.1m |
Intangibles | 103.2m |
Other Non-Current Assets | 5.5m |
Current Liabilities | 29.3m |
Accounts Payable | 1.7m |
Accrued Liabilities | 25.5m |
Other Current Liabilities | 2.2m |
Non-Current Liabilities | 16.6m |
Other Non-Current Liabilities | 16.6m |
Earnings Waterfall
LeMaitre Vascular Inc
Revenue
|
213m
USD
|
Cost of Revenue
|
-67.5m
USD
|
Gross Profit
|
145.6m
USD
|
Operating Expenses
|
-96m
USD
|
Operating Income
|
49.6m
USD
|
Other Expenses
|
-8.3m
USD
|
Net Income
|
41.3m
USD
|
Free Cash Flow Analysis
LeMaitre Vascular Inc
USD | |
Free Cash Flow | USD |
LMAT Profitability Score
Profitability Due Diligence
LeMaitre Vascular Inc's profitability score is 61/100. The higher the profitability score, the more profitable the company is.
Score
LeMaitre Vascular Inc's profitability score is 61/100. The higher the profitability score, the more profitable the company is.
LMAT Solvency Score
Solvency Due Diligence
LeMaitre Vascular Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Score
LeMaitre Vascular Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
LMAT Price Targets Summary
LeMaitre Vascular Inc
According to Wall Street analysts, the average 1-year price target for LMAT is 101.433 USD with a low forecast of 85.85 USD and a high forecast of 122.85 USD.
Dividends
Current shareholder yield for LMAT is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
LMAT Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company is headquartered in Burlington, Massachusetts and currently employs 450 full-time employees. The company went IPO on 2006-10-19. The firm develops, manufactures and markets vascular devices to address the needs of vascular surgeons, and to a lesser degree, other specialties, such as cardiac surgeons, general surgeons and neurosurgeons. The company sold its principal product in the United States, Europe, the United Kingdom, Canada and Asia Pacific. The firm sales its products and services primarily through a direct sales force. Its products and services offering includes Allografts, Angioscopes, Balloon Catheters for Embolectomy and Thrombectomy, Balloon Catheters for Occlusion and Perfusion, Bovine Grafts, Vascular and Cardiac Patches, Carotid Shunts, Closure Systems, Ovine Vascular Grafts, Polyester Vascular Grafts, ePTFE Vascular Grafts, Radiopaque Tape, and Valvulotomes.
Contact
IPO
Employees
Officers
The intrinsic value of one LMAT stock under the Base Case scenario is 54.085 USD.
Compared to the current market price of 105.425 USD, LeMaitre Vascular Inc is Overvalued by 49%.